08.04.17
The 10th annual meeting of the Silab-Jean Paufique Corporate Foundation took place on June 29, 2017 at the Silab headquarters in an atmosphere of scientific presentations and friendly discussions, said the company.
To mark this anniversary, the prize-winners from the last ten years or their laboratory managers, the members of the Scientific Committee and the Governing Body as well as Silab company employees gathered together with founder Paufique. In total, 140 people attended the various scientific presentations.
In particular, it was an opportunity for Thomas Bertero, the tenth award winner unanimously selected by the foundation's Scientific Committee, to present his research and work. His project entitled "The influence of the mechanical properties of the tumoral niche on the Squamous Cells Carcinoma metabolism" will receive financial support from the foundation for three years.
The foundation was established in 2007 with the aim of providing active, constant support for fundamental and applied research in the diagnosis, prognosis and treatment of dermatological pathologies, and more specifically, skin cancer.
To mark this anniversary, the prize-winners from the last ten years or their laboratory managers, the members of the Scientific Committee and the Governing Body as well as Silab company employees gathered together with founder Paufique. In total, 140 people attended the various scientific presentations.
In particular, it was an opportunity for Thomas Bertero, the tenth award winner unanimously selected by the foundation's Scientific Committee, to present his research and work. His project entitled "The influence of the mechanical properties of the tumoral niche on the Squamous Cells Carcinoma metabolism" will receive financial support from the foundation for three years.
The foundation was established in 2007 with the aim of providing active, constant support for fundamental and applied research in the diagnosis, prognosis and treatment of dermatological pathologies, and more specifically, skin cancer.